Prospects of RNA interference therapy in respiratory viral diseases: update 2006. (Q36627248)

15 August 2017

1 reference

title

Prospects of RNA interference therapy in respiratory viral diseases: update 2006. (English)

1 reference

15 August 2017

1 reference

1

Sailen Barik

1 reference

15 August 2017

Vira Bitko

2

1 reference

PubMed ID

17049013

15 August 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

Expert Opinion on Biological Therapy

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

11

1 reference

15 August 2017

1151-1160

1 reference

New drugs and treatment for respiratory syncytial virus

15 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus: the virus, the disease and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus infections: recent prospects for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus infections: characteristics and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Antiviral applications of RNAi for coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Pandemic influenza threat and preparedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

The genesis of a pandemic influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

RNA virus mutations and fitness for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus genetic and antigenic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Animal pneumoviruses: molecular genetics and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus-induced immunoprotection and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Prevention and treatment of respiratory syncytial virus infection in infants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus infections in congenital heart defects--hospitalizations and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Control of nonsegmented negative-strand RNA virus replication by siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Development of gene-specific double-stranded RNA drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Silence of the transcripts: RNA interference in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Support plasmids and support proteins required for recovery of recombinant respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Mapping the transcription and replication promoters of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

RNAi as an antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Sequence analysis of the polymerase L gene of human respiratory syncytial virus and predicted phylogeny of nonsegmented negative-strand viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

RSV entry inhibitors block F-protein mediated fusion with model membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Paramyxovirus accessory proteins as interferon antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhibition of influenza virus matrix (M1) protein expression and virus replication by U6 promoter-driven and lentivirus-mediated delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Inhibition of influenza virus production in virus-infected mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Protection against lethal influenza virus challenge by RNA interference in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

RNA interference and chemically modified small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

siRNAs: applications in functional genomics and potential as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Synthetic shRNAs as potent RNAi triggers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

Noise amidst the silence: off-target effects of siRNAs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.11.1151

10.1517/14712598.6.11.1151

21 January 2018

Identifiers

DOI

1 reference

release_erlzt6tzhzghnpsdyh2zubox3i

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/erlzt6tzhzghnpsdyh2zubox3i

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17049013

1 reference

PubMed ID

17049013